A new Medicare program that began July 1, 2026, may make certain GLP-1 weight-management medications available to eligible people with Medicare prescription drug coverage for a $50 monthly copay
We do think these drugs are going to be a big disruptor for the food industry, and they are here to stay, so how well-positioned are brands to take advantage? Fiber moving into the spotlight
Help with long-term weight management in overweight adults with at least one weight-related medical condition, such as high blood pressure or high cholesterol, alongside diet and exercise
Ensure the provider requires comprehensive medical evaluations and oversight from licensed healthcare professionals
For skin and hair goals, topical application is the safer and more appropriate route to discuss with a provider
Our IGF-1 LR3 Peptide is stored and handled according to industry guidelines to ensure stability